Tilray Target of Unusually Large Options Trading (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY) was the target of some unusual options trading on Wednesday. Investors bought 67,207 call options on the stock. This represents an increase of 89% compared to the average volume of 35,652 call options.

Tilray Price Performance

NASDAQ TLRY opened at $1.21 on Friday. The company has a fifty day moving average of $1.49 and a 200 day moving average of $1.68. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.57 and a current ratio of 2.47. Tilray has a 1 year low of $1.20 and a 1 year high of $2.97.

Tilray (NASDAQ:TLRY) last posted its earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting analysts’ consensus estimates of ($0.04). The firm had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The company’s quarterly revenue was up 13.0% on a year-over-year basis. During the same period last year, the firm earned ($0.10) EPS. On average, research analysts anticipate that Tilray will post -0.14 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Carl A. Merton acquired 26,000 shares of the firm’s stock in a transaction dated Friday, November 15th. The shares were acquired at an average cost of $1.36 per share, with a total value of $35,360.00. Following the acquisition, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at approximately $35,360. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.87% of the company’s stock.

Institutional Investors Weigh In On Tilray

A number of large investors have recently made changes to their positions in TLRY. Ferguson Wellman Capital Management Inc. purchased a new stake in Tilray in the third quarter valued at $26,000. Signature Estate & Investment Advisors LLC acquired a new stake in Tilray in the 2nd quarter valued at approximately $29,000. Jeppson Wealth Management LLC acquired a new position in Tilray during the second quarter worth $33,000. Vanguard Capital Wealth Advisors purchased a new position in Tilray during the 2nd quarter valued at about $34,000. Finally, Pallas Capital Advisors LLC purchased a new position in shares of Tilray in the second quarter valued at approximately $37,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm reduced their target price on Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research note on Friday, October 11th.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.